Drug Profile
RO 646198
Alternative Names: IpidantLatest Information Update: 05 Dec 2008
Price :
$50
*
At a glance
- Originator Roche
- Class Anxiolytics
- Mechanism of Action Nociceptin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 25 Jul 2006 No development reported - Preclinical for Anxiety disorders in Switzerland (unspecified route)
- 16 Aug 2002 A preclinical study has been added to the Anxiety Disorders pharmacodynamics section
- 23 Apr 2002 A preclinical study has been added to the Anxiety Disorders pharmacodynamics section